Although SPARC has been reported to be dysregulated in several different types of cancers48,49, has been associated with prostate cancer progression and bone metastasis50–53, and has been suggested as a possible target for cancer therapeutics48,54,55, the elevated global protein level of SPARC in this study was determined to be nonspecific for prostate cancer. This evidence concerns the gene SPARC and prostate cancer.